Article
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Breast cancer research and treatment - 1 Feb 2011
Grann Victor R, Patel Priya R, Jacobson Judith S, Warner Ellen, Heitjan Daniel F, Ashby-Thompson Maxine, Hershman Dawn L, Neugut Alfred I
Abstract excerpt
UNLABELLED: Comparative effectiveness research has become an integral part of health care planning in most developed countries. In a simulated cohort of women, aged 30-65, who tested positive for BRCA1 or BRCA2 mutations, we compared outcomes of mammography with and without MRI, prophylactic oophorectomy with and without mastectomy, mastectomy alone, and chemoprevention. METHODS: Using Treeage 9.02 software, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.